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Abstract
A new type of test is presented for genome-wide association studies using a case-control design. It
is referred to as the adaptive two-stage (ATS) analysis, being based on both the Hardy-Weinberg
disequilibrium trend test (HWDTT) and the Cochran-Armitage trend test (CATT). The procedure
for the ATS is to screen single-nucleotide polymorphisms (SNPs) using the HWDTT in a first stage,
and then test a reduced number of SNPs that pass the screening step in a second stage using the
CATT. In the Genetic Analysis Workshop 15 simulated data set, this ATS analysis captured, after
Bonferroni correction, the region from 32447.149 kb to 32859.819 kb and the region around
37363.880 kb that are close to the actual trait loci on chromosome 6. We compared the ATS with
other ways of combining the p-values of the HWDTT and the CATT, the classical form of Fisher's
test and a weighted form of Fisher's test. Results showed that the proposed ATS has good
performance and could detect the regions containing a susceptibility locus.
Background
The advance of genotyping technologies and reduction of
genotyping costs are resulting in genome-wide association
studies using 100,000 to 500,000 (100 k–500 k) single-
nucleotide polymorphisms (SNPs) across the whole
genome in which tests for association are performed
between each SNP and a disease in a case-control design.
However, one of the big challenges of genome-wide asso-
ciation studies is the issue of multiple testing [1].
Zhang et al. [2] proposed an adaptive two-stage (ATS)
analysis using two trend tests, the Hardy-Weinberg dise-
quilibrium trend test (HWDTT) and the Cochran-Armit-
age trend test (CATT). All samples are used in both stages
in the same way that Van Steen et al. [3] applied a two-
stage analysis of family-based association. The adaptive
two-stage analysis proposed here uses the HWDTT in the
first stage to screen the SNPs and then tests a reduced
number of SNPs that pass this screening step using the
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CATT in the second stage. The conservative Bonferroni-
corrected p-value of an allele-based test is obtained for
each SNP, but it is only necessary to correct for the
number of SNPs included in the second-stage analysis.
As an alternative approach, Fisher's combination of p-val-
ues, referred to as Fisher's test, was considered by Zhang et
al. [2]. Because the HWDTT and CATT are asymptotically
independent under the null hypothesis, Fisher's test statis-
tic [4] is given by T = -2log(pHWDTT) - 2log(pCATT), which
under the null has a chi-square distribution with 4 df.
Recently, Hwang et al. [5] extended Fisher's test to a
"weighted" version that aims to maximize overall statisti-
cal power for a given significance level (0 ≤ α ≤ 1) using a
nonparametric distribution with a Gaussian Kernel den-
sity.
In this study, we applied the ATS analysis to the Genetic
Analysis Workshop (GAW15) simulated data set in order
to find susceptibility disease genes. We compared the
results of the ATS with those of the CATT, the HWDTT, the
classical Fisher test (CFT), and the weighted Fisher test
(WFT). The ATS was Bonferroni-corrected for multiple
testing, so, for the sake of comparison, the CATT, HWDTT,
and Fisher tests (CFT and WFT) are also adjusted using the
same correction method.
Methods
For the ATS analysis of association, Zhang et al. [2]
applied the HWDTT and the CATT to case-control studies.
Song and Elston [6] and Zhang et al. [2] showed that these
two statistics are asymptotically independent under the
null hypothesis of no association. Therefore, they used all
samples for both stages of the analysis. For the first stage
of the proposed ATS analysis, the HWDTT is applied to
test each SNP at the significance level α1 chosen on the
basis of the conditional power of the HWDTT. The small-
est α1 is chosen such that the power is at least 1 - β, where
β is the type II error.
Denote the estimators of the genotype frequencies in cases
and controls   and   for i = 0, 1, 2, so that
 and   are estimators of the
frequencies of the allele A in cases and controls. Song and
Elston [6] considered the difference in disequilibrium
coefficients between cases (D1) and controls (D0), where
D1 = p2 - (p2 + p1/2)2 and D0 = q2 - (q2 + q2/2)2. The HWDTT
statistic can be written as
where  ni  = (ri  +  si) and  . The asymptotic
power of the HWDTT can then be written as
where
f(a, b) = (1 - 2b - a)2b(1 - b) + 2ab(b + a/2)(1 - 2b - a) + (b
+ a/2)2a(1 - a),
 = f(r'p1 + s'q1, r'p2 + s'q2)/(r's'), r' ≈ r/n and s' ≈ s/n,
 = nVar(D1 - D0),
Φ is the distribution function of the standard normal N(0,
1), and
 is the 100(1 - α1/2)th percentile of N(0, 1).
The SNPs for which the null hypotheses are rejected in the
first stage are tested in the second stage analysis by the
CATT at the level α2 = α'/(mα1), where α' is obtained by
the parametric bootstrap to control the overall type I error
rate of the ATS analysis. Then α2 controls the overall type
I error rate to α (taken to be 0.05) for a total of m simul-
taneous hypothesis tests (SNPs). As in Van Steen et al. [3],
the overall p-value of the ATS is the p-value of the second
analysis, which here is the CATT.
Data
We used the GAW15 simulated Problem 3 data set for
rheumatoid arthritis (RA), which includes 100 replicates.
Each replicate contains 1500 families with an affected sib-
ling pair and 2000 unaffected control subjects. To obtain
a sample of cases and controls, we randomly chose one
case from each affected sib pair. Thus, from each replicate
we selected 1500 cases with RA and 2000 controls. In
order to compare the performance of all methods in a
small sample size, we randomly sampled 200 cases and
200 controls from each of the 100 replicate samples of
1500 cases and 2000 controls. To examine type I error
rate, we concentrated on 100 markers that were at least
20,000 kb distant from the identified peaks on chromo-
some 6. Therefore, the total number of marker tests to
examine type I error was 10,000 (100 markers × 100 rep-
licates). To examine power, we concentrated on all 674
markers on chromosome 6 using only one replicate of
200 cases and 200 controls. Among these 674 markers, 5
markers are causative, in the region between 32447.149
kb and 37363.880 kb on chromosome 6.
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Results
The results for type I error are shown in Table 1 for the
nominal significance levels α = 0.05 and α = 0.001. Table
1 shows that all the test statistics have nominal signifi-
cance level close to the actual significance levels.
Without multiple testing corrections, the HWDTT, CATT,
CFT, and WFT showed strong associations (p  < 0.001)
with a susceptibility disease gene in the region (Fig. 1,
green line) between 32447.149 kb and 32859.819 kb on
chromosome 6. In addition, the HWDTT, CATT, and
Fisher tests (CFT and WFT) showed a significant associa-
tion (p < 0.05) at 37363.880 kb, which was close to a trait
locus (37233.784 kb). The results also indicated that i)
CATT and CFT have similar power near the peak, ii) CFT
is more powerful than WFT near the peak, and iii) the
HWDTT is not powerful near the peak.
With Bonferroni multiple testing correction, Table 2
shows the locations of the SNP markers that are signifi-
cantly associated with RA. In Table 2, the p-values for
HWDTT, CATT, WFT, and CFT are compared at the signif-
icance level 0.05/674 = 7.42 × 10-5. To obtain the p-value
of the ATS analysis, first we calculated the asymptotic
power of the HWDTT for α1 = 0.01 to 1.00 with incre-
ments of 0.01 for each of the 674 SNPs. Then for each SNP
we chose the α1 that had at least 80% conditional power.
Results showed that 535 SNPs had p-values of HWDTT
less than this α1 and these were analyzed in the second
stage. Then we obtained the adjusted overall level for α'
using the parametric bootstrap with increments of 0.001
and 10,000 replications. For example, for 80% condi-
tional power, the SNP in location 32447.149 kb requires
α1 = 0.77 in the first stage. Then, based on the bootstrap,
we obtained α' = 0.03. Thus, the adjusted level required
for the second stage is α2 = 0.03/(674 × 0.77) = 5.78 × 10-
5. The p-values of the HWDTT is 0.53 <α1 = 0.77. Thus, the
SNP in location 32447.149 kb is significant in the first
stage. The p-value of the CATT in the second stage is 2.7 ×
10-15  <α2  = 5.8 × 10-5. Hence, the SNP in location
32447.149 kb is significant when the adaptive two-stage
analysis is applied.
Applying the ATS with the optimal α2, the three SNPs in
the region between 32447.149 kb and 32772.203 kb were
associated with RA. In particular, after Bonferroni correc-
tion the ATS showed that the SNP at 37363.880 kb was
associated with RA. In the region between 32447.149 kb
and 32859.819 kb, the CATT and CFT had Bonferroni-cor-
rected average p-values < 1.34 × 10-12 and p < 5.80 × 10-7,
respectively. In addition, the corrected p-value of CFT is
0.000802 for a marker at location 37363.880 kb. How-
ever, the Bonferroni-corrected p-value of WFT is not signif-
icant. This could indicate that WFT with Bonferroni
correction may be too conservative, because it already
minimizes the number of false positives and false nega-
tives.
Discussion
We have presented the use of a new method for genome-
wide association studies with optimal choice of signifi-
cance level to maximize the power and at the same time
asymptotically control the overall type I error. The ATS
analysis uses two independent test statistics-here the
HWDTT and the CATT. We compared the performance of
the HWDTT, CATT, Fisher's tests combining the HWDTT
and CATT, and the ATS in this data set with Bonferroni
correction for multiple testing and found that the ATS had
good performance. Compared to WFT or CFT, the ATS
showed higher power in this study. CFT captured the
region that is close to a trait locus and gave higher power
than WFT, but had p < 0.05 in regions that were distant
from the true locations, so that the falsepositive rate of
CFT seems to be higher than that of WFT in these data.
This agrees with the original paper [5] reporting a lower
false-positive rate for WFT.
In this study, we applied all test statistics to the GAW15
simulated data. However, the simulated effect near the
peak is so strong that all test statistics were able to detect
the susceptibility disease gene on chromosome 6 with a
sample size as small as 200 cases and 200 controls; the
Bonferroni corrected p-values were significant for the
CATT, CFT, and ATS. Zhang et al. [2] showed that the ATS
is more powerful than the CATT and CFT when applied to
real data in an association study of 96 cases and 50 con-
trols that used 103,611 SNPs for a genome-wide associa-
tion study of age-related macular degeneration [7].
Table 1: Type I error rates
Test statistics α = 0.05 α = 0.001
Hardy-Weinberg disequilibrium trend test 0.0468 0.0013
Cochran-Armitage trend test 0.0488 0.0008
Classical Fisher's test 0.0503 0.0017
Weighted Fisher's test 0.0502 0.0010
Adaptive two-stage 0.0492 0.0012BMC Proceedings 2007, 1(Suppl 1):S147 http://www.biomedcentral.com/1753-6561/1/S1/S147
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Table 2: The locations of the SNP markers that are significantly associated with RA after Bonferroni correction at the significance level 
α = 0.05
ATSb
Location (kb) HWDTTa CATTa WFTa CFTa Stage 1c Stage 2d
32447.149 NSe 2.65 × 10-15 NS 4.96 × 10-14 0.53 < 0.77 2.7 × 10-15 < 5.8 × 10-5
32499.465 NS <1.0 × 10-17 NS <1.10 × 10-16 0.65 < 0.83 1.0 × 10-17 < 6.3 × 10-15
32521.277 NS <1.0 × 10-17 NS <1.10 × 10-16 NS NS
32772.203 NS 5.36 × 10-15 NS 3.44 × 10-9 0.27 < 0.65 5.4 × 10-15 < 5.7 × 10-5
37363.880 NS NS NS 1.19 × 10-6 0.0003 < 0.02 0.0003 < 0.0011
aThe p-values should be compared with 0.05/674 = 7.42 × 10-5.
bThe p-value should be compared with the optimal level in the two stages.
cThe level in the first stage with conditional power at least 80% (α1)
dThe adjusted level for the second stage (α2 = α'/(674α1))
eNS: no significance
Results of SNP markers using HWDTT, CATT, CFT, and WFT for chromosome 6 Figure 1
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Finally, we should note the limitations of the ATS method
we used. The ATS analysis will be more costly than other
two-stage analysis studies, which uses separate portions of
the sample for each stage, because the ATS analysis uses all
subjects in both stages. In addition, the ATS analysis is
more computationally intensive than the other tests
because it is a necessary to obtain the adjusted overall
level for α' using the parametric bootstrap.
Conclusion
Using the ATS analysis, a sample size as small as 200 cases
and 200 controls showed good performance after Bonfer-
roni correction for association with a susceptibility dis-
ease gene in the region between 32447.149 kb and
37363.880 kb on chromosome 6.
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